Latest Information Update: 22 Aug 2005
At a glance
- Originator Targacept
- Developer sanofi-aventis; Targacept
- Class Neuroprotectants; Pyridines
- Mechanism of Action Nicotinic receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Alzheimer's disease